The Russian Direct Investment Fund hopes that one of the new coronavirus vaccines developed in that country will be registered within 10 days, according to the head of the fund, Kirill Dmítriyev.
“In that case, we will overtake all other countries, including the United States, ” said the head of the sovereign wealth fund in an interview on the Rossiya 24 channel.
According to the official, the production volume of this new vaccine could reach 10 million per month by the end of this year.
The Health Minister of Russia, Mikhail Murashko, confirmed last Saturday that the phase of clinical trials of the vaccine prepared by the National Research Center for Epidemiology and Microbiology Gamaleya in conjunction with the Russian Ministry of Defense had been completed and that it was preparing the package of documents necessary to register the medication.
Once the registration certificate is obtained, the vaccine will begin to be supplied among the country’s population, first among the members of special groups such as doctors and teachers, while a mass vaccination is scheduled for October, the minister said.
The Defense Ministry noted that the trial results unequivocally showed the development of an immune response in all volunteers, with no side effects, complications, or unwanted reactions.
Meanwhile, the Russian Prime Minister, Mikhail Mishustin, announced last month that the country 17 scientific organizations are developing more than 25 different vaccines against the new coronavirus. So far, Russia has recorded 856,264 positive cases and 14,207 deaths from covid-19.